Using a biophysical and structuralproteomics approach similar to our previous work,24 we show that USP30-I-1 is highly selectiveand potent against endogenous USP30 when compared to the >40 otherendogenous DUBs identified in the neuroblastoma-derived SH-SY5Y cellline. This evidence concerns the gene USP30 and neuroblastoma.